Lars W. Wormhoudt

The Use of Humanin VitroMetabolic Parameters to Explore the Risk Assessment of Hazardous Compounds: The Case of Ethylene Dibromide

Jan-Peter H. T. M. Ploemen, Lars W. Wormhoudt, Guido R.M.M. Haenen et al. · Toxicology and Applied Pharmacology · 1997 · 46 citations

Pharmacy, Toxicology, Toxicodynamics +11

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial

Jorine H. Savonije, C.J. van Groeningen, Aart van Bochove et al. · European Journal of Cancer · 2005 · 42 citations

Medicine, Hematology, Oncology +15

Polymorphism in the glutathione conjugation activity of human erythrocytes towards ethylene dibromide and 1,2-epoxy-3-(p-nitrophenoxy)-propane

J.H.T.M. Ploemen, Lars W. Wormhoudt, Ben van Ommen et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 1995 · 29 citations

Life Sciences, Biochemistry, Redox Biochemistry +7

A physiologically-based pharmacokinetic(PB-PK) model for ethylene dibromide: relevance of extrahepatic metabolism

A.M. Hissink, Lars W. Wormhoudt, Philip J. Sherratt et al. · Food and Chemical Toxicology · 2000 · 23 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

In vitro inhibition of rat and human glutathione S-transferase isoenzymes by disulfiram and diethyldithiocarbamate

J.P.H.T.M. Ploemen, M L van Iersel, Lars W. Wormhoudt et al. · Biochemical Pharmacology · 1996 · 22 citations

Life Sciences, Biochemistry, Pharmacology +9